Sabur Technology focuses on the licensing of innovative proprietary product ideas from renowned university and individual investigators. Sabur Technology then finds the most direct path to commercialization of these products.
Dennis Sabo is the Managing Partner at Sabur Technologies, a company focusing on licensing and commercializing high potential medical device technologies. As Managing Partner, Mr. Sabo utilizes his over thirty years experience in the medical device industry to not only identify leading-edge technologies but to further coordinate the complex processes of manufacturing, regulatory and commercialization of these technologies into valuable market oriented products.
Dr. Burd is a co-founder and General Partner of Sabur Technology. Previously Dr. Burd was Founder & CEO of Oculir, developing a remarkable new non-invasive glucose testing technology. Prior to Oculir, Dr. Burd was a General Partner of Windamere Venture Partners and Chairman & CEO of MiraMedica, a company developing computer-aided detection technology for enhanced cancer diagnosis. MiraMedica was sold to Kodak in August 2003. Dr. Burd was previously President & CEO of DexCom, where he directed the company’s work to develop, manufacture and market the first long-term implantable glucose sensor for people with diabetes. In April 2005, DexCom completed a successful IPO, valuing the company at up to $600 million.
Amy Rasdal is an Associate at Sabur Technologies. She has extensive management experience in the areas of Operations, Product Development, Corporate Development and Marketing. She has the proven ability to solve complex problems, manage crises and enable people to accomplish difficult tasks. Ms. Rasdal is particularly skilled in putting together the right project management process and leading its implementation. She leads by example in the belief that people do their best when truly given the chance to do so.